These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 16291652)

  • 1. Mutational analysis of the SH2-kinase linker region of Bruton's tyrosine kinase defines alternative modes of regulation for cytoplasmic tyrosine kinase families.
    Guo S; Wahl MI; Witte ON
    Int Immunol; 2006 Jan; 18(1):79-87. PubMed ID: 16291652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.
    Lindvall JM; Blomberg KE; Väliaho J; Vargas L; Heinonen JE; Berglöf A; Mohamed AJ; Nore BF; Vihinen M; Smith CI
    Immunol Rev; 2005 Feb; 203():200-15. PubMed ID: 15661031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain.
    Mohamed AJ; Yu L; Bäckesjö CM; Vargas L; Faryal R; Aints A; Christensson B; Berglöf A; Vihinen M; Nore BF; Smith CI
    Immunol Rev; 2009 Mar; 228(1):58-73. PubMed ID: 19290921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design and purification of human Bruton's tyrosine kinase SH3-SH2 protein for structure-function studies.
    Nera KP; Brockmann E; Vihinen M; Smith CI; Mattsson PT
    Protein Expr Purif; 2000 Dec; 20(3):365-71. PubMed ID: 11087675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
    Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
    J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a novel mutation in the SRC homology domain 2 (SH2) of Bruton's tyrosine kinase and direct female carrier evaluation in a family with X-linked agammaglobulinemia.
    Schuster V; Seidenspinner S; Kreth HW
    Am J Med Genet; 1996 May; 63(1):318-22. PubMed ID: 8723128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
    Mattsson PT; Vihinen M; Smith CI
    Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
    Sideras P; Müller S; Shiels H; Jin H; Khan WN; Nilsson L; Parkinson E; Thomas JD; Brandén L; Larsson I
    J Immunol; 1994 Dec; 153(12):5607-17. PubMed ID: 7989760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.
    Qin S; Chock PB
    Biochemistry; 2001 Jul; 40(27):8085-91. PubMed ID: 11434777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
    Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
    Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of peripheral blood B cells in patients with X-linked agammaglobulinemia.
    Nonoyama S; Tsukada S; Yamadori T; Miyawaki T; Jin YZ; Watanabe C; Morio T; Yata J; Ochs HD
    J Immunol; 1998 Oct; 161(8):3925-9. PubMed ID: 9780159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X-linked agammaglobulinemia.
    Hagemann TL; Rosen FS; Kwan SP
    Hum Mutat; 1995; 5(4):296-302. PubMed ID: 7627183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
    Lin L; Czerwinski R; Kelleher K; Siegel MM; Wu P; Kriz R; Aulabaugh A; Stahl M
    Biochemistry; 2009 Mar; 48(9):2021-32. PubMed ID: 19206206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phosphorylation site in Bruton's tyrosine kinase selectively regulates B cell calcium signaling efficiency by altering phospholipase C-gamma activation.
    Guo S; Ferl GZ; Deora R; Riedinger M; Yin S; Kerwin JL; Loo JA; Witte ON
    Proc Natl Acad Sci U S A; 2004 Sep; 101(39):14180-5. PubMed ID: 15375214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of two naturally occurring missense mutations in the structure and function of Bruton agammaglobulinemia tyrosine kinase.
    Vargas-Hernández A; López-Herrera G; Maravillas-Montero JL; Vences-Catalán F; Mogica-Martínez D; Rojo-Domínguez A; Espinosa-Rosales FJ; Santos-Argumedo L
    IUBMB Life; 2012 Apr; 64(4):346-53. PubMed ID: 22378381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function.
    Rawlings DJ
    Clin Immunol; 1999 Jun; 91(3):243-53. PubMed ID: 10370369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
    Gaspar HB; Lester T; Levinsky RJ; Kinnon C
    Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype correlation in Bruton's tyrosine kinase deficiency.
    Teimourian S; Nasseri S; Pouladi N; Yeganeh M; Aghamohammadi A
    J Pediatr Hematol Oncol; 2008 Sep; 30(9):679-83. PubMed ID: 18776760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe B cell deficiency and disrupted splenic architecture in transgenic mice expressing the E41K mutated form of Bruton's tyrosine kinase.
    Dingjan GM; Maas A; Nawijn MC; Smit L; Voerman JS; Grosveld F; Hendriks RW
    EMBO J; 1998 Sep; 17(18):5309-20. PubMed ID: 9736610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.